Biocon Ltd.

Syngene International extends research collaboration with Bristol Myers Squibb through 2035, expanding drug development services.

Biocon raises Rs 4,150 crore through QIP. Funds to buy Mylan (Viatris) stake in Biocon Biologics. Focus on biosimilars, diabetes, oncology.

Biocon Pharma receives USFDA approval for generic Everolimus tablets, used to treat tuberous sclerosis complex (TSC).

Biocon Biologics to launch Trastuzumab, Nivolumab, Pembrolizumab biosimilars for cancer. Expanding oncology portfolio. Details here.

Biocon out-licenses its diabetes drug Semaglutide to Ajanta Pharma for export to 23 countries in Africa, Middle East & Central Asia.

Eternal reports 73% profit rise in Q3. Deepinder Goyal resigns as CEO, Albinder Singh Dhindsa appointed. Read the latest updates.

Amagi Media Labs shares debut weakly, settling nearly 4% lower than the IPO price. IPO subscribed 30.22 times.

Stock markets decline for 3rd day due to geopolitical tensions. Sensex sinks below 82k. Foreign fund outflows add pressure.

Pesticide industry urges tighter e-commerce rules to curb fake product sales. Calls for mandatory authorization to protect farmers.

Rupee crashes to a record low of 91.73 against the US dollar amid foreign fund outflows and global uncertainty. Key factors explained.

Rashmi Group signs Rs 12,500 cr MoU with Telangana at WEF 2026, creating 12,000 jobs. AB InBev also expands in Telangana.

Sargad signs MoU with Telangana to invest Rs 1,000 crore. Focus on aviation MRO facility and clean energy projects. WEF 2026 discussions.

India will become the 3rd largest economy by 2028 or earlier, says Vaishnaw & Gopinath at WEF. Key challenges & opportunities discussed.

Eternal reports 73% profit rise in Q3. Deepinder Goyal resigns as CEO, Albinder Singh Dhindsa appointed. Read the latest updates.

Amagi Media Labs shares debut weakly, settling nearly 4% lower than the IPO price. IPO subscribed 30.22 times.